ITI Pharma and Healthcare Fund - Regular Plan - Growth Option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 08-11-2021
AUM:
₹ 210.46 Cr
Expense Ratio
2.35%
Benchmark
NIFTY Healthcare TRI.
ISIN
INF00XX01BL5
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 3.67 | 20.57 | - |
| NIFTY Healthcare TRI | 13.55 | 25.97 | 16.03 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
15.5901
Last change
0.04 (0.2527%)
Fund Size (AUM)
₹ 210.46 Cr
Performance
10.81% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Fund Manager
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.76 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.959999999999999 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 6.21 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.489999999999999 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.9799999999999995 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.55 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.6900000000000004 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.66 |
| ALKEM LABORATORIES LIMITED EQ | 3.36 |
| ASTER DM HEALTHCARE LIMITED EQ | 2.81 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 93.39 |
| Chemicals | 2.54 |
| Financial Services | 1.41 |
| Capital Goods | 0.9 |